RESEARCH IN SENSITIVITY TO ANTIBIOTICS, ANTISEPTICS IN PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM PATIENTS WITH INFECTIOUS COMPLICATIONS by Nazarchuk, O. A. et al.
ISSN 2413-6077. IJMMR 2017 Vol. 3 Issue 164
PU
B
LI
C 
H
EA
LT
H
 A
N
D
 E
PI
D
EM
IO
LO
G
Y
dOI 10.11603/IJMMR.2413-6077.2017.1.7000
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WITh INfEcTIOUs cOmPLIcATIONs
O. A. Nazarchuk, D. V. Paliy, N. I. Osadchuk
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Background. Infections caused by Pseudomonas are one of the topical issues of medicine.
Objective. The aim of the research was to study sensityvity to antibiotics, antiseptics of P. aeruginosa clini-
cal strains that cause infectious complications in patients with burns.
Methods. Microbiological study of biological material, received from 435 patients with burns of the 3rd 
stages (2011-2015 years). In early terms of burn disease 127 clinical strains of P. aeruginosa were isolated from 
patients. Standard methods were used to identify clinical isolates of P. aeruginosa by their morphological, tinc-
tirial, culture and biochemical properties. The research of antimicrobial action of antiseptics, antibiotics against 
Pseudomonas were carried out by means of standard methods according to the Directive of the Ministry of Health 
of Ukraine (no. 167 from 05.04.2007 р.) and guidelines of national committee of clinical and Laboratory Study 
(NCCLS, 2002). 
Results. It was established that P. aeruginosa caused infectious complications in 23.9% of patients among 
other pathogens. Clinical isolates of P. aeruginosa were found to be low sensitive to amoxicillin/clavulanate 
(30.76%), ceftazidime (25.92%), cefoperazonum/sulbactam (46.15%), aztreonam (51.85%), tobramycin (38.46%), 
amicacin (70.34%), doxiciclini (26.92%), fluoroquinolones (59.26%). The analitical progistic criteria of decrease 
of sensitivity to ceftazidime, cefepim, meropenem and gatifloxacin were found in P. aeruginosa. This pathogen 
was determined to be sensitive to decasan ®, antimicrobial composition of decamethoxine ®, iodine pvidone.
Conclusions. Clinical strains of Pseudomonas aeruginosa, being highly resistant to antibiotics, are also very 
sensitive to antiseptics decasan ®, antimicrobial of decamethoxine®, povidone iodine.
KEy wORDS: antibiotics; antiseptics; infectious complications; resistance.
Introduction
Infection is a determinative factor of reco-
very of patients with different diseases in critical 
state. It is the main reason of severe compli-
cations and mortality among seriously ill pa-
tients. Infectious complications, caused by such 
non-fermenting Gram-negative bacilli as Pseu-
domonas, are one of the topical matter in con-
tem porary medicine. The incidence of infectious 
complications, caused by P. aeruginosa has no 
tendency to decrease, despite the use of up-to-
date methods of diagnostics and treatment of 
diseases with antimicrobial agents. Mana-
gement of P. aeruginosa related infection is of 
great significance among burn patients [1, 2].
It is established that unsatisfactory results 
of prevention, treatment of infectious compli-
cations of burns are due to distribution of 
P. aeruginosa polyantibioticresistant strains in 
surgical clinics. environmental factors Active 
antimicrobial prevention and management by 
environmental factors provide selective effect 
on bacteria, which obtaines new qualities under 
this action (resistance to environmental factors, 
high virulence and resistance to antibiotics). 
Such qualities are determined by genome of 
microorganisms and can be caused by muta-
tions that prove high adaptation to bacteria. In 
these cases, infectious complications caused by 
P. aeruginosa are still a current issue [3, 4].
Current principles of prevention and treat-
ment of infectious complications in patients 
with burns include antimicrobials straight after 
clinical sympthoms are evidenced. So, wide 
spectrum antimicrobials are empirically used. 
Nevertheless in conditions of high resistance 
of microorganisms to antibiotics the absolute 
therapeutic effect cannot be achieved. Complex 
approach is one of the most perspective ten-
dency in fight against Pseudomonas infection, 
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it include combined use of antibiotics and 
antiseptics. That is why, the research in the 
effectiveness of antimicrobials against strains 
of P. aeruginosa that cause infectious compli-
cations is essential [5].
The aim of the research was to study sen-
sitivity of P. aeruginosa clinical strains, isolated 
from patients with infectious complications, to 
antibiotics and antiseptics
Methods
Microbiological research of wound exudate 
samples taken from burn surfaces of 435 pati-
ents with deep burns of the 3rd stages took place 
in 2011–2015. All patients enrolled into the 
research had infectious complications. They 
were treated in burns centre of N. I. Pirogov 
Vinnitsya Regional Clinical Hospital. Microbio-
logical research was carried out in bacteriological 
laboratory of the Department of Microbiology 
of Vinnytsya National Pirogov Memorial Medical 
University of the Ministry of Health of Ukraine. 
The research consisted of isolation of pure 
culture of pathogens identified by their mor-
phological, tinctirial, culture and biochemical 
properties. The research samples were sepa-
rated by sterile plug before antibacterial 
therapy. 645 strains of opportunistic bacteria 
were isolated from patients with burn trauma.
During the first 7 days of patients’ treatment 
in the burn centre P. aeruginosa caused infec-
tious complications in 23.9% of cases in com-
parison with other etiological pathogens. So 
the sensitivity of P. aeruginosa isolates to 
antibiotics and antiseptics was studied. Bio-
chemical activity of clinical strains of P. aeru-
ginosa was defined by means of test-system 
(NEFERMtest-24 (PLIVA – Lachema a. s., Chech 
Republic), which consisted of biochemical tests 
(indol, arginin, urease, lysine, glucose, fructose, 
inositol, saccharose, phosphatase, beta-galac-
tosidase, beta-glucuronidase, N-acetyl-beta-D-
glucosaminidase, mannitol, xylose, cellobiose, 
galactose, nitrates, nitrites, eskulin, gamma- 
glutamyltransferase, lactose, maltose, trega-
lose, citrate of Simonce). Cytocromeoxidase 
activity was additionally studied (OXY-test). 
The study of bacteria sensitivity to antibiotics 
and antiseptics (decasan® (DS), miramistine 
(MR), chlorhexidine digluconate (CHD), povidon 
iodine (PI), antimicrobial composition of deca-
methoxine® (AMC) was conducted by standard 
methods according to The Directive of the 
Ministry of Health of Ukraine (No. 167 from 
05.04.2007 р.) and guidelines of national 
Committee of Clinical and Laboratory Study 
(NCCLS, 2002). Sensitivity rate of P.aeruginosa 
clinical strains to antiseptics was evaluated by 
the value of minimal bactericidal concentration 
(MBcC, in mkg/ml) that was obtained by the 
serial broth dilution method [7].
In the research mathematical and statistical 
analysis of sensitivity of P. aeruginosa clinical 
strains to antibiotics, antiseptics were conduc-
ted. The methods of statistical analysis, used in 
the research, enabled definition regular rela-
tionship between numeric values of variable 
indications and probability of realization of 
these values in array observations. to find out 
the effectiveness of antibiotics current methods 
of mathematical prediction were used. So, 
accurate sensitivity of P. aeruginosa and its 
extrapolation on the studied system by building 
a series of standard normative mathematical 
models of predicted sensitivity of the pathogen 
to antibiotics was foreseen. Thus, analytical 
methods with concretization of absolute and 
relative optimum meanings were used.
Predictive models of P. aeruginosa sensitivity 
to antibiotics of different groups were inves-
tigated as summation of mathematical formu-
las, which were used to determine these qua-
lities of microorganisms accordingly to their 
meanings, extrinsic and initial conditions and 
time. the significance of the results, possible 
sensitivity rate to antimicrobials was assessed 
by the coefficient of determination (r2). The 
obtained data underwent computer processing 
by means of original programs “STATISTICA 7”; 
“Matlab 7.11”. For each group of microorganisms 
strains for each year of study arithmetic mean 
(М), error arithmetic mean (m), standard devi-
ation (σ) were defined. Using the methods of 
applied mathematics the approximation and 
interpolation of the data were conducted. Due 
to this analytic dependence the possible dyna-
mic of sensitivity rate of P. aeruginosa strains, 
isolated from the patients, was estimated [8].
Results
As the result of the research, 154 clinical 
strains of P. aeruginosa were isolated and 
identified that looked like typical bacteria of this 
specimen due to their tinctirial, morphological, 
and cultural properties. Strains of P. aeruginosa, 
isolated from the patients, had typical bioche-
mical features (Table 1).
All clinical isolates of P. aeruginosa (100%) 
produced haemolysins, oxidase and decom po-
sed D-mannitol.
As the results of the research, it was proved 
that P. aeruginosa was sensitive to aminopenicillin 
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combined with amoxicillin/clavulanate only in 
12.30–30.76% of cases (Fig. 1).
The study of cephalosporins effectiveness 
showed that sensitivity of P. aeruginosa clinical 
isolated to ceftazidime had not exceeded 
25.92% for five years of our study. the efficacy 
of ceftazidime was decreased by 8.5% in 2014–
2015. By means of mathematical analysis the 
Table 1. Enzymatic properties of isolated strains of P. aeruginosa (n 154)
Test P. aeruginosa 
Oxidase +
Catalyse +
D- cellobiose -
Glucose +
γ- glutamyltransferase +
D-mannitol +
L₁-prolinarylamidase +
Lipase -
Urease +/-
Malonate +
Phosphatase +/-
L- lactate -
N-Acetyl-beta-D-Glucosaminidase -
D- mannose -
L- histidine -
Fig. 1. Sensitivity of P. aeruginosa isolates, received from seriously ill patients with burns (%).
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predicted decrease of P. aeruginosa sensitivity 
to ceftazidime has been proven (Formula 1; 
Fig. 2).
 2
1Ceftazidim
ln ln /a bx x c x x
=
+ +
, (1)
a=-55358.47; b=2.2527981; c=1.1111315е+10
According to the results of the study of ce-
pha losporins activity, the efficacy of cefepime 
was not proved (20.55–30.76%). Prognostic 
curve of sensitivity of P. aeruginosa clinical 
strains to cefepime could refer to parabolic 
function, presenting future decrease of the 
efficacy of this antibiotic. it was found out that 
P. aeruginosa colonized at burn surfaces was 
resistant to cefalosprins combined with sulbac-
tam. Only 20.55–44.44% of P. aeruginosa clinical 
strains were sensitive to cefoperazone/sul-
bactam.
In 2011–2015, the tendency of decrease of 
P. aeruginosa clinical strains sensitivity to mero-
penem (28.75%), imipenem (24.34%) was regis-
tered. Predictive analysis of P. aeruginosa sen-
sitivity to meropenem was revealed by its linear 
decreasing in 2011-2015 (formula 2; fig. 3): 
Meropenem=a+bx3+cx/lnx, (2)
a=1719659.7; b=8.4437694е-05; c=-9101.5317
Similar decrease of Pseudomonas sensitivity 
to imipenem was defined in the research.
The estimation of P. aeruginosa sensitivity 
to aminoglycosides proved low efficacy of tob-
ramicin (16.23–38.46%). The decrease of P. aeru-
ginosa sensitivity to amikacin was also evidenced 
in the research (Formula 3; Fig. 4). 
Amikacin  
   2,5
1,5
dy a bx cx
x
= + + + , (3)
a=-5.8244079e+9; b=2892515.8; c=-8.0030078; 
d=1.3157016e+14; х – year
Thus, P. aeruginosa clinical strains were 
found to be significantly sensitive to amikacin 
in 2011 (70.37%). But in 2015 the number of 
P. aeruginosa sensitive strains was significantly 
lower (16.23%). Analytical prediction revealed 
linear decrease of P. aeruginosa sensitivity to 
amikacin.
It was found out, that isolates of P. aeruginosa 
were of low sensitivity to aztreonam (34.61–
51.85%). Five-year-study of P. aeruginosa sen-
sitivity to aztreonam presented its depression 
(21.73%) (Formula 4; Fig. 5).
Aztreonam   y=a+bx2+cx4+dx6  (4)
a=-6.5573499e+8; b=485.57507; c=-0.000119856; 
d=9.861468e-12; х – years
Fig. 2. Predictive sensitivity to ceftazidime of P. aeruginosa clinical strains, received from the patients with burn 
wounds (%).
Fig. 3. Predictive sensitivity of P. aeruginosa strains to meropenem (%).
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In P. aeruginosa clinical strains of low anti-
biotic sensitivity, different sensitivity rates to 
antiseptic remedies were found (Table 2).
In the research, clinical strains of P. aerugi-
nosa were found to be sensitive to AMC (MBcC 
53.15±1.27 mkg/ml). Inhibitory effect of DC® 
(46.65±0.76 mkg/ml), MR (47.83±2.04 mkg/ml) 
did not significantly differ from aMC (р>0.05). 
Clinical strains of P. aeruginosa were resistant 
to ChD. Thus, MBcC of ChD versus P. aerugi-
nosa exceeded 165.85±10.9 mkg/ml that proved 
its low efficacy against these bacteria. DC® and 
MR had in 1.8 times higher antimicrobial qual-
ities versus P. aeruginosa in comparison with 
ChD (р<0.001). antimicrobial activity of aMC 
was 3 times higher than in ChD (р<0.001). an-
tibiotic resistant clinical strains of P. aeruginosa 
were studied to obtain high sensitivity to bac-
tericidal concentrations of povidone iodine that 
is contained in the official pharmaceutical form 
of this remedy. 
Discussion
However, in the research the obtained data 
proved that the amount of isolates of P. aerugi-
nosa in general population was high and 
reached 23.9% of all microorganisms, isolated 
from burn wounds in patients, who suffered from 
infectious complications. Such tendency did not 
differ from established trend of the increasing 
importance of P.aeruginosa as a prominent 
pathogen of infectious complications [2, 5].
The results of the research proved low sen-
sitivity of P. aeruginosa clinical strains to antibi-
Fig. 4. Predictive sensitivity of P. aeruginosa strains to amikacin (%).
Fig. 5. Predictive sensitivity of P. aeruginosa strains to aztreonam. 
Table 2. Antimicrobial activity of antiseptics against P. aeruginosa isolates
Antiseptic
Minimal inhibitory  
concentrations
Minimal bactericidal  
concentrations
(М±m), mkg/ml
Antimicrobial composition of 
decamethoxine® (AMC)
31.0±0.17 53.15±1.27
Decasan® (DC) 46.65±0.76† 91.34±1.69*
Miramistin (MR) 47.83±2.04† 96.85±3.25*
Clorhexidine digluconate (ChD) 106.3±4.76*** 165.85±10.9***
Povidon iodine 3858.27±192.13*** 6742.13±397.27***
notes. † – р>0.05, * – р<0.05 ** – р<0.01, *** – р<0.001 in comparison with aMC.
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otics of different groups. The low sensitivity of 
Pseudomonas to antibiotics, containing beta-
lactam ring in their molecule, was defined. 
However, in some clinics these antibiotics are 
widely used as agents of choice for prevention 
and treatment of infectious complications in 
patients with burns. low efficacy of cephalo-
sporins against P. aeruginosa according to their 
sensitivity rate was also determined. Higher 
sensitivity rate to carbapenems was proved in 
P. aeruginosa (74.07–77.77%). The estimation of 
the antibiotic sensitivity of P. aeruginosa to 
aminoglycosides showed their low effective-
ness (16.23-38.46%). It was proved, that P. aeru-
ginosa isolates, received from the patients with 
deep burns, were of low sensitivity to aztre-
onam (34.61–51.85%) [3, 4].
Bactericidal qualities of antiseptics were 
established that proved high efficacy of deca-
methoxine, decasan, povidone iodine against 
clinical strains of P. aeruginosa, as pharmaceu-
tical forms contained in adequate doses of 
these drugs. In the majority of cases bacteri-
cidal concentrations of miramistin exceeded 
the dose in the remedy officinal form [2, 6].
Conclusions
Clinical strains of P. аeruginosa, which cause 
infectious complications in seriously ill patients 
with burn disease, have moderate sensitivity to 
beta-lactam antibiotics (amoxicillin/clavula-
nate – 30.76%; ceftazidime – 25.92%; cefopera-
zone/sulbactam – 46.15%; meropenem – 
77.77%; imipenem – 74.07%; aztreonam – 
51.85%); aminoglycosides (tobramicin – 38.46%; 
amikacin – 70.34%).
Analytical models predict parabolic de-
crease of sensitivity of P. aeruginosa to ceftazi-
dime, cefepime; lineal tendency of decrease of 
their sensitivity to meropenem, imipenem. 
Clinical strains of Pseudomonas aeruginosa, 
being highly resistant to antibiotics, save their 
high sensitivity to antiseptics decasan®, antimi-
crobial composition of decamethoxine®, povi-
done iodine. The use of antiseptics is very 
promising in prevention and treatment of infec-
tious complications caused by P. aeruginosa.
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